Cargando…
Bempedoic Acid for Lipid Management in the Indian Population: An Expert Opinion
Lipid-lowering is a central theme in the management of patients with atherosclerotic cardiovascular disease (ASCVD) and heterozygous familial hypercholesterolemia (HeFH), with statins being currently used as the first-line lipid-lowering agent (LLAs). Bempedoic acid (BA) has been recently approved f...
Autores principales: | Hiremath, Jagdish, Mohan, J C, Hazra, Prakash, Sawhney, JP S, Mehta, Ashwani, Shetty, Sadanand, Oomman, Abraham, Shah, Mahesh K, Bantwal, Ganapathi, Agarwal, Rajeev, Karnik, Rajiv, Jain, Peeyush, Ray, Saumitra, Das, Sambit, Jadhao, Vibhuti, Suryawanshi, Sachin, Barkate, Hanmant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040092/ https://www.ncbi.nlm.nih.gov/pubmed/36987470 http://dx.doi.org/10.7759/cureus.35395 |
Ejemplares similares
-
Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India
por: Ray, Saumitra, et al.
Publicado: (2023) -
Retrospective Study to Assess the Effect of Telmisartan on Urine Albumin to Creatinine Ratio in Indian Hypertensive Patients
por: Sharma, Balram, et al.
Publicado: (2021) -
A Prospective, Randomized Open-Label Study for Assessment of Antihypertensive Effect of Telmisartan Versus Cilnidipine Using Ambulatory Blood Pressure Monitoring (START ABPM Study)
por: Sawant, Rahul, et al.
Publicado: (2023) -
Bempedoic acid for the treatment of dyslipidemia
por: Marrs, Joel C, et al.
Publicado: (2020) -
Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)